Top Markets
#1 DogBull DogBull +54.40%
#2 Siren Siren +31.81%
#3 OriginTrail OriginTrail +15.19%
#4 Verus Coin Verus Coin +11.30%
#5 Tutorial Tutorial +8.83%
#6 Yield Basis Yield Basis +8.48%
#7 Prom Prom +8.33%
#8 Falcon Finance Falcon Finance +7.80%
#9 COTI COTI +7.42%
#10 Stargate Finance Stargate Finance +6.97%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rank in Stocks #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Share Price
$0.3479
Last synced: 2024-08-21
Market Cap
$94.92M
Change (1 day)
0.64%
Change (1 year)
0.00%
Country
US
Trade Asensus Surgical, Inc. (ASXC)

Category

Healthcare
P/S ratio for Asensus Surgical, Inc. (ASXC)
P/S ratio as of August 2026 TTM: 11.07
According to Asensus Surgical, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.07. At the end of 2022 the company had a P/S ratio of 11.58.
P/S ratio history for Asensus Surgical, Inc. from 2000 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 11.07 19.26%
2023 9.28 -19.85%
2022 11.58 -62.15%
2021 30.60 117.81%
2020 14.05 359.72%
2019 3.06 -84.27%
2018 19.43 -96.30%
2017 524.82 -57.95%
2016 1.25K 0.00%
2015 0.00 -100.00%
2014 5.54K 1,060.92%
2013 477.12 12,992.32%
2012 3.64 0.00%
2011 0.00 -100.00%
2010 -8.47M 0.00%
2009 0.00 0.00%
2008 0.00 -100.00%
2007 -2.83K 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 46.44 5,218.44%
2002 0.87 -47.76%
2001 1.67 3.81%
2000 1.61 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -62.66%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -54.52%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -74.84%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -66.85%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
- -
DE